A chill or a tap: simple tricks that could take the sting out of baby shots

NCT ID NCT07779681

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study tests two simple, non-drug methods to reduce pain during routine vaccination in 12-month-old infants. One group gets a cold spray on the injection site before the shot, another gets a gentle tapping technique near the site during the injection, and a third gets standard care. Researchers will measure pain using a validated scale, along with crying time and vital signs, to see if either method helps.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cold spray and the Helfer Skin Tap technique, two non-drug methods to ease injection pain
What this could lead to
If effective, these simple techniques could offer drug-free ways to reduce pain and distress during routine infant vaccinations.
What could go wrong
The trial is small and early, and pain is subjective—results may not apply to all infants or other vaccines. The techniques may not meaningfully reduce pain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 12 months

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Parent or legal guardian has at least primary school education. * Parent or legal guardian agrees for the infant to participate in the study. * The infant is scheduled to receive the pneumococcal conjugate vaccine by - intramuscular injection. * The infant was born between 38 and 42 weeks of gestation. * The infant is 12 months old. * The infant's body weight corresponds to the 50th percentile. Exclusion Criteria: * Parent or legal guardian is illiterate. * The infant was born preterm or postterm. * The infant attends the family health center for a vaccine other than the pneumococcal conjugate vaccine. * The infant has a congenital anomaly, birth asphyxia, or any chronic disease. * The infant received an analgesic medication within at least 4 hours before vaccination.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Injection pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Procedural

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.